NASDAQ: PTCT - PTC Therapeutics, Inc.

Yield per half year: +68.58%
Sector: Healthcare

Share chart PTC Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

PTC Therapeutics, Inc., биофармацевтическая компания, занимается открытием, разработкой и коммерциализацией лекарств для лечения редких заболеваний. Компания предлагает Трансларна (аталурен) и Эмфлаза (дефлазакорт) для лечения нонсенс-мутации мышечной дистрофии Дюшенна у амбулаторных пациентов.

More details
Компания занимается разработкой Translarna, которая находится в фазе 2 клинических исследований для лечения нонсенс-мутации аниридии и синдрома нонсенс-мутации Драве CDKL5; и RG7916 и RO7034067 для лечения пациентов со спинальной мышечной атрофией, а также PTC596 и PTC299, низкомолекулярный ингибитор дигидроорататдегидрогеназы (DHODH), который ингибирует синтез пиримидиновых нуклеотидов de novo, который находится в фазе 1 стадии клинической разработки для лечения больных раком. . Компания также разрабатывает кандидатный продукт для генной терапии, который включает PTC-AADC для лечения дефицита декарбоксилазы ароматических L-аминокислот. Он сотрудничает с F. Hoffman-La Roche Ltd и Hoffman-La Roche Inc., а также с Фондом спинальной мышечной атрофии с целью разработки и коммерциализации соединений, выявленных в рамках спонсируемой им программы исследований по спинальной мышечной атрофии; научно-исследовательское сотрудничество с Массачусетской больницей общего профиля для лечения редких генетических заболеваний, вызванных пре-мРНК; и Akcea Therapeutics, Inc. для коммерциализации Тегседи и Вайливра для лечения редких заболеваний в Латинской Америке и Карибском бассейне. Компания PTC Therapeutics, Inc. была основана в 1998 году, ее штаб-квартира находится в Саут-Плейнфилде, штат Нью-Джерси.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

P/S 9.26
P/BV 4.78
EV/EBITDA -21.16
EBITDA -0.1168
Цена ао 40.94
Сайт http://www.ptcbio.com
Число акций ао 0.07484 млрд
Выручка 0.307
Див.доход ао 0
ISIN US69366J2006
Валюта usd
IPO date 2013-06-20
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: +2.66% (41.4)
Change price per week: +9.76% (38.72)
Change price per month: +17.53% (36.16)
Change price per 3 month: +26.68% (33.55)
Change price per half year: +68.58% (25.21)
Change price per year: +86.65% (22.77)
Change price per 3 year: +5.51% (40.28)
Change price per 5 year: +4.32% (40.74)
Change price per year to date: +77.16% (23.99)
All parameters

Underestimation

Title Value Grade
P/S 2.2 7
P/BV -2.52 0
P/E 0 0
EV/EBITDA -16.73 0
Total: 4.25

Efficiency

Title Value Grade
ROA, % -32.92 0
ROE, % 76.55 10
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -17.02 10
Total: 7

Growth impulse

Title Value Grade
Yield Revenue, % 205.48 10
Yield Ebitda, % -3.41 0
Yield EPS, % 96.08 9
Total: 7.6
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
19.04.2024 22.04.2024 Klein Matthew B.
CHIEF EXECUTIVE OFFICER		 Sale 24.89 83 655 3361 0 0 link
17.04.2024 19.04.2024 Klein Matthew B.
CHIEF EXECUTIVE OFFICER		 Sale 25.14 32 858 1307 0 0 link
17.04.2024 19.04.2024 Pauwels Eric
CHIEF EXECUTIVE OFFICER		 Sale 25.14 19 785 787 0 0 link
06.09.2023 08.09.2023 Young Alethia
Director		 Sale 39.86 465 007 11666 0 -0.02 link
06.09.2023 08.09.2023 Young Alethia
Director		 Purchase 27.85 324 898 11666 0 0.02 link
09.01.2023 11.01.2023 Utter Christine Marie
SVP, FINANCE & CAO		 Sale 41.66 29 412 706 0 0 link
09.01.2023 11.01.2023 Peltz Stuart Walter
CHIEF EXECUTIVE OFFICER		 Sale 41.66 11 623 279 0 0 link
09.01.2023 11.01.2023 Peltz Stuart Walter
CHIEF EXECUTIVE OFFICER		 Sale 41.66 74 405 1786 0 0 link
09.01.2023 11.01.2023 Pauwels Eric
CHIEF BUSINESS OFFICER		 Sale 41.66 35 744 858 0 0 link
09.01.2023 11.01.2023 Klein Matthew B.
CHIEF OPERATING OFFICER		 Sale 41.66 30 453 731 0 0 link
09.01.2023 11.01.2023 Boulding Mark Elliott
EXEC. VP AND CLO		 Sale 41.66 34 786 835 0 0 link
09.01.2023 11.01.2023 Hill Emily Luisa
CHIEF FINANCIAL OFFICER		 Sale 41.66 31 578 758 0 0 link
09.01.2023 11.01.2023 Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER		 Sale 41.66 1 791 43 0 0 link
09.01.2023 11.01.2023 Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER		 Sale 41.66 29 829 716 0 0 link
13.04.2022 15.04.2022 Boulding Mark Elliott
EXEC. VP AND CLO		 Sale 45.17 102 807 2276 0 0 link
25.01.2022 27.01.2022 Almstead Neil Gregory
Chief Technical Ops Officer		 Sale 39.31 1 690 43 0 0 link
25.01.2022 27.01.2022 Hill Emily Luisa
Chief Financial Officer		 Sale 39.31 8 294 211 0 0 link
25.01.2022 27.01.2022 Pauwels Eric
Chief Business Officer		 Sale 39.31 14 112 359 0 0 link
25.01.2022 27.01.2022 Peltz Stuart Walter
Chief Executive Officer		 Sale 39.31 12 972 330 0 0 link
01.02.2021 02.02.2021 Svoronos Dawn
Director		 Sale 56.96 28 822 506 0 0 link
01.02.2021 02.02.2021 Peltz Stuart Walter
Chief Executive Officer		 Sale 56.96 16 120 283 0 0 link
01.02.2021 02.02.2021 Peltz Stuart Walter
Chief Executive Officer		 Sale 56.96 112 097 1968 0 0 link
01.02.2021 02.02.2021 Pauwels Eric
Chief Business Officer		 Sale 56.96 20 620 362 0 0 link
01.02.2021 02.02.2021 Almstead Neil Gregory
Chief Technical Ops Officer		 Sale 56.96 1 595 28 0 0 link

Institutions Volume Share, %
Wellington Management Group, LLP 9816603 12.81
Vanguard Group Inc 8800843 11.49
Blackrock Inc. 7634122 9.97
RTW Investments LP 7423970 9.69
Armistice Capital, LLC 6864000 8.96
State Street Corporation 4633955 6.05
Camber Capital Management LP 4000000 5.22
COWEN AND COMPANY, LLC 3725626 4.86
Janus Henderson Group PLC 2612593 3.41
FMR, LLC 1814421 2.37

ETF Share, % Profitability for 1 year, % Dividends, %
Motley Fool Small-Cap Growth ETF 3.69 41.755028983875 5.41
Direxion mRNA ETF 4.89
iShares Neuroscience and Healthcare ETF 4.39568 20.843202273804 0.03
Avantis Responsible U.S. Equity ETF 0.00593 34.234643935068 1.45257
Avantis U.S. Equity ETF 0.00371 37.016870113839 1.59151
Virtus LifeSci Biotech Products ETF 1.41975 41.945031712474 0.13953
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.18137 37.61291904149 1.59225
ProShares Ultra Nasdaq Biotechnology 0.18076 58.954326923077 0.85651
ProShares UltraShort Nasdaq Biotechnology 0.4 -43.384373773066 1.76
BNY Mellon US Small Cap Core Equity ETF 0.13359 37.872537301924 1.75333
Vanguard ESG U.S. Stock ETF 0.01 37.253765932793 1.26927
iShares ESG Aware MSCI USA Small-Cap ETF 0.05099 39.294631710362 1.49366
First Trust Multi Cap Growth AlphaDEX Fund 0.11224 48.187044451288 1.02425
Fidelity MSCI Health Care Index ETF 0.03507 21.181088923024 1.46057
First Trust Small Cap Growth AlphaDEX Fund 0.54286 51.937052783242 1.22182
First Trust Small Cap Core AlphaDEX Fund 0.20263 38.56717191346 1.87983
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.12259 41.265441455097 1.41955
Global X Guru Index ETF 1.62261 46.282792415311 0.71623
ProShares Hedge Replication ETF 0.01655 6.8665973306333 1.47892
Humankind US Stock ETF 0.01726 22.971795629061 1.99919
Invesco Nasdaq Biotechnology ETF 0.26702 29.399255715045 0.8565
iShares Morningstar Small-Cap ETF 0.06073 37.681332167863 1.60498
iShares Morningstar Small-Cap Growth ETF 0.08016 41.553945249597 0.72598
iShares Morningstar Small Cap Value ETF 0.04061 40.493824576094 2.50476
Inspire Small/Mid Cap ETF 0.2159 38.577885952712 1.92038
iShares Russell 2000 Growth ETF 0.15722 47.42032299557 0.6026
iShares Russell 3000 ETF 0.00492 37.942616648456 1.43482
iShares Morningstar Small-Cap ETF 0.06073 410.50632631881 1.60498
iShares Morningstar Small-Cap Growth ETF 0.08016 757.51743375174 0.72598
iShares Morningstar Small-Cap Value ETF 0.04061 252.86210418795 2.50476
Direxion Daily S&P Biotech Bull 3x Shares 0.30035 5201.8382352941 0.25924
Invesco Russell 2000 Dynamic Multifactor ETF 0.04903 30.7149376331 1.64004
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.01848 39.993646759848 1.75869
Invesco Dorsey Wright Healthcare Momentum ETF 1.07011 56.526768010575 0.12263
Schwab U.S. Small-Cap ETF 0.06928 -30.367553865653 1.51433
Schwab U.S. Broad Market ETF 0.005 -53.970149253731 1.43354
SPDR SSGA US Small Cap Low Volatility Index ETF 0.0396 39.202262226167 2.97092
SPDR Portfolio MSCI Global Stock Market ETF 0.00758 29.55850326668 2.19607
FlexShares Morningstar US Market Factor Tilt Index Fund 0.0034 37.307074947524 1.69572
ProShares UltraPro Russell2000 0.06028 125.96465921385 1.47873
Vanguard Russell 3000 ETF 0 38.467141890837 1.43817
Vanguard Russell 2000 Growth ETF 0.15 46.764050831914 0.60264
Vanguard Russell 2000 ETF 0.1 41.410408042578 1.48801
Principal Healthcare Innovators ETF 0.27263 631.79771324797 0.8416
Future Tech ETF 0.27263 412.888593871 0.8416



Head Job title Payment Year of birth
Mr. Mark Elliott Boulding Executive VP & Chief Legal Officer 824.09k 1961 (63 years)
Mr. Eric Pauwels Chief Business Officer 847.67k 1961 (63 years)
Ms. Christine Utter Senior VP, Chief Accounting Officer & Head of People Services 595.54k 1978 (46 years)
Dr. Allan Steven Jacobson Ph.D. Co-Founder, Chairman of Scientific Advisory Board & Independent Director 145k 1946 (78 years)
Dr. Neil Almstead Ph.D. Chief Technical Operations Officer 829.97k 1967 (57 years)
Dr. Stuart W. Peltz Ph.D. Co-Founder, Senior Consultant & Member of Scientific Advisory Board 1.54M 1960 (64 years)
Alex Kane Investor Relations Officer N/A
Dr. Matthew B. Klein F.A.C.S., M.D., M.S. CEO & Director 995.4k 1972 (52 years)
Mr. Pierre Gravier M.S. Chief Financial Officer N/A 1986 (38 years)
Dr. Lee Golden M.D., Ph.D. Executive VP & Chief Medical Officer 1968 (56 years)

Address: United States, South Plainfield, NJ , 100 Corporate Court - open in Google maps, open in Yandex maps
Website: http://www.ptcbio.com